Physician profile

Daniel Park

Plastic Surgery · Marietta, GA

NPI 1952546533

$943.89

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$419.69

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mentor Worldwide LLC $382.62 2019-2024 Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander
Integra Lifesciences Corporation $259.82 2020-2023 Durasorb Monofilament Mesh
Revance Therapeutics, INC. $101.97 2024 Daxxify
Sientra, INC. $92.14 2022
Acelrx Pharmaceuticals, INC. $53.04 2021-2022
Apollo Endosurgery US INC $31.36 2019
Apyx Medical Corporation $22.94 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel Park

$943.89

in general payments reported 2019-2025

Years
2019-2024
Top company
Mentor Worldwide LLC

https://glasscript.com/doctor/179828/daniel-park

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.